Characteristics of Included Studies
This SR includes nine RCTs with a total of 793 children with AD, whose
ages ranged from four months to 18 years old. The main characteristics
of the nine eligible studies are summarized in Table 1. Of the nine
RCTs, five reported the efficacy outcome using SCORAD, and four used
SASSAD. Eight studies reported the safety outcome. Five studies
administered the interventions orally and four intradermally.